2223 related articles for article (PubMed ID: 20670887)
21. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway.
Peterson TR; Sengupta SS; Harris TE; Carmack AE; Kang SA; Balderas E; Guertin DA; Madden KL; Carpenter AE; Finck BN; Sabatini DM
Cell; 2011 Aug; 146(3):408-20. PubMed ID: 21816276
[TBL] [Abstract][Full Text] [Related]
22. Connecting mTORC1 signaling to SREBP-1 activation.
Bakan I; Laplante M
Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814
[TBL] [Abstract][Full Text] [Related]
23. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
[TBL] [Abstract][Full Text] [Related]
24. Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.
Liu D; Bordicchia M; Zhang C; Fang H; Wei W; Li JL; Guilherme A; Guntur K; Czech MP; Collins S
J Clin Invest; 2016 May; 126(5):1704-16. PubMed ID: 27018708
[TBL] [Abstract][Full Text] [Related]
25. The late endosome is essential for mTORC1 signaling.
Flinn RJ; Yan Y; Goswami S; Parker PJ; Backer JM
Mol Biol Cell; 2010 Mar; 21(5):833-41. PubMed ID: 20053679
[TBL] [Abstract][Full Text] [Related]
26. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
27. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.
Wen YA; Xiong X; Zaytseva YY; Napier DL; Vallee E; Li AT; Wang C; Weiss HL; Evers BM; Gao T
Cell Death Dis; 2018 Feb; 9(3):265. PubMed ID: 29449559
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells.
Li S; Oh YT; Yue P; Khuri FR; Sun SY
Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295
[TBL] [Abstract][Full Text] [Related]
30. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation.
Morita M; Gravel SP; Chénard V; Sikström K; Zheng L; Alain T; Gandin V; Avizonis D; Arguello M; Zakaria C; McLaughlan S; Nouet Y; Pause A; Pollak M; Gottlieb E; Larsson O; St-Pierre J; Topisirovic I; Sonenberg N
Cell Metab; 2013 Nov; 18(5):698-711. PubMed ID: 24206664
[TBL] [Abstract][Full Text] [Related]
31. mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.
Minard AY; Tan SX; Yang P; Fazakerley DJ; Domanova W; Parker BL; Humphrey SJ; Jothi R; Stöckli J; James DE
Cell Rep; 2016 Sep; 17(1):29-36. PubMed ID: 27681418
[TBL] [Abstract][Full Text] [Related]
32. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
Shackelford DB; Vasquez DS; Corbeil J; Wu S; Leblanc M; Wu CL; Vera DR; Shaw RJ
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11137-42. PubMed ID: 19541609
[TBL] [Abstract][Full Text] [Related]
33. mTORC1 signaling and the metabolic control of cell growth.
Ben-Sahra I; Manning BD
Curr Opin Cell Biol; 2017 Apr; 45():72-82. PubMed ID: 28411448
[TBL] [Abstract][Full Text] [Related]
34. Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis.
Karmaus PWF; Herrada AA; Guy C; Neale G; Dhungana Y; Long L; Vogel P; Avila J; Clish CB; Chi H
J Exp Med; 2017 Sep; 214(9):2629-2647. PubMed ID: 28784627
[TBL] [Abstract][Full Text] [Related]
35. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
[TBL] [Abstract][Full Text] [Related]
36. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ.
Kurebayashi Y; Nagai S; Ikejiri A; Ohtani M; Ichiyama K; Baba Y; Yamada T; Egami S; Hoshii T; Hirao A; Matsuda S; Koyasu S
Cell Rep; 2012 Apr; 1(4):360-73. PubMed ID: 22832227
[TBL] [Abstract][Full Text] [Related]
37. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.
Dormond O; Contreras AG; Meijer E; Datta D; Flynn E; Pal S; Briscoe DM
J Immunol; 2008 Dec; 181(11):8088-95. PubMed ID: 19018001
[TBL] [Abstract][Full Text] [Related]
38. Multiple regulatory layers of SREBP1/2 by SIRT6.
Elhanati S; Kanfi Y; Varvak A; Roichman A; Carmel-Gross I; Barth S; Gibor G; Cohen HY
Cell Rep; 2013 Sep; 4(5):905-12. PubMed ID: 24012758
[TBL] [Abstract][Full Text] [Related]
39. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM
PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957
[TBL] [Abstract][Full Text] [Related]
40. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
